Pulse- Where do we Draw the Line: Evaluating the Risk of Serotonin Syndrome in Individuals Concomitantly Prescribed Linezolid and Selective Seratonin Uptake Inhibitor

December 21, 2022

New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.

Serotonin syndrome can be a life-threatening complication of medications including linezolid and selective serotonin reuptake inhibitors (SSRIs). Despite this risk, the use of linezolid may be necessary due to life-threatening infectious processes. This education plans to discuss the risk versus benefit of linezolid and SSRI use in various clinical scenarios.

Target Audience

Pharmacist

Learning Objectives

• Describe the pathophysiology and implications of serotonin syndrome in the setting of multi-serotonergic active medications.

• Discuss the risk of serotonin syndrome in the setting of simultaneous linezolid and various (or multiple) SSRIs

• Discuss the risk vs benefit of concomitant linezolid and SSRI use in various clinical scenarios

Additional Information

AttachmentSize
File Audience Disclosure slide_7.pptx460.26 KB
File Pulse 12-21-22.docx17.54 KB
Course summary
Available credit: 
  • 1.00 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
Course opens: 
12/21/2022
Course expires: 
01/21/2023
Event starts: 
12/21/2022 - 12:00pm EST
Event ends: 
12/21/2022 - 1:00pm EST

New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.

Serotonin syndrome can be a life-threatening complication of medications including linezolid and selective serotonin reuptake inhibitors (SSRIs). Despite this risk, the use of linezolid may be necessary due to life-threatening infectious processes. This education plans to discuss the risk versus benefit of linezolid and SSRI use in various clinical scenarios.

UPMC Presbyterian
Pittsburgh, PA
United States

Michael Mast, PharmD

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Pharmacy (CPE)

This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.

 

Available Credit

  • 1.00 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
Please login or register to take this course.